Verena Boßung

697 total citations
20 papers, 454 citations indexed

About

Verena Boßung is a scholar working on Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Verena Boßung has authored 20 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pediatrics, Perinatology and Child Health, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Epidemiology. Recurrent topics in Verena Boßung's work include Neonatal Respiratory Health Research (6 papers), Pregnancy and preeclampsia studies (4 papers) and Birth, Development, and Health (3 papers). Verena Boßung is often cited by papers focused on Neonatal Respiratory Health Research (6 papers), Pregnancy and preeclampsia studies (4 papers) and Birth, Development, and Health (3 papers). Verena Boßung collaborates with scholars based in Germany, Switzerland and United States. Verena Boßung's co-authors include S. Ananth Karumanchi, Ravi Thadhani, Thomas Benzing, Henning Hagmann, Peter Mallmann, Achim Rody, Angela Kribs, A Jank, Tom H. Lindner and Tuelay Kisner and has published in prestigious journals such as Circulation, Nature Communications and PLoS ONE.

In The Last Decade

Verena Boßung

18 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Verena Boßung Germany 9 286 267 126 98 48 20 454
Evelyn A. Huhn Switzerland 14 264 0.9× 340 1.3× 74 0.6× 64 0.7× 17 0.4× 29 542
Raymond P. Naden United States 13 139 0.5× 194 0.7× 95 0.8× 104 1.1× 34 0.7× 21 561
Felice Sorrentino Italy 16 190 0.7× 322 1.2× 62 0.5× 55 0.6× 22 0.5× 58 688
Laura Prieto Argentina 13 132 0.5× 96 0.4× 72 0.6× 49 0.5× 30 0.6× 24 436
A. Martinelli Italy 10 211 0.7× 199 0.7× 55 0.4× 40 0.4× 8 0.2× 19 391
Seyfettin Uludağ Türkiye 12 330 1.2× 464 1.7× 169 1.3× 31 0.3× 9 0.2× 37 655
Raquel Romero‐Carmona Spain 9 190 0.7× 270 1.0× 69 0.5× 30 0.3× 20 0.4× 12 359
Grażyna Kurzawińska Poland 10 95 0.3× 116 0.4× 57 0.5× 50 0.5× 8 0.2× 55 344
Christopher Novak United States 10 167 0.6× 60 0.2× 51 0.4× 96 1.0× 20 0.4× 22 334
B. Schauf Germany 11 121 0.4× 204 0.8× 31 0.2× 60 0.6× 10 0.2× 32 406

Countries citing papers authored by Verena Boßung

Since Specialization
Citations

This map shows the geographic impact of Verena Boßung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verena Boßung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verena Boßung more than expected).

Fields of papers citing papers by Verena Boßung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verena Boßung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verena Boßung. The network helps show where Verena Boßung may publish in the future.

Co-authorship network of co-authors of Verena Boßung

This figure shows the co-authorship network connecting the top 25 collaborators of Verena Boßung. A scholar is included among the top collaborators of Verena Boßung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verena Boßung. Verena Boßung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haslinger, Christian, Torsten Hothorn, Verena Boßung, et al.. (2025). Effects of early factor XIII replacement in postpartum hae morrhage: study protocol for a multicentre, open-label, randomised, controlled, investigator-initiated trial. BMJ Open. 15(5). e100262–e100262. 1 indexed citations
2.
Graspeuntner, Simon, Egbert Herting, Guido Stichtenoth, et al.. (2025). Persistent reduction of Bifidobacterium longum in the infant gut microbiome in the first year of age following intrapartum penicillin prophylaxis for maternal GBS colonization. Frontiers in Immunology. 16. 1540979–1540979.
3.
Fortmann, Mats Ingmar, Christoph Härtel, Dirk Olbertz, et al.. (2024). Use and Impact of Pessary, Cerclage, and Progesterone for the Secondary Prevention of Preterm Birth: Data from the German Neonatal Network. Zeitschrift für Geburtshilfe und Neonatologie. 228(3). 246–254. 1 indexed citations
5.
Graspeuntner, Simon, et al.. (2023). First-Day-of-Life Rectal Swabs Fail To Represent Meconial Microbiota Composition and Underestimate the Presence of Antibiotic Resistance Genes. Microbiology Spectrum. 11(3). e0525422–e0525422. 4 indexed citations
6.
Boßung, Verena, Julia Pagel, Achim Rody, et al.. (2022). Timing of antimicrobial prophylaxis for cesarean section is critical for gut microbiome development in term born infants. Gut Microbes. 14(1). 2038855–2038855. 17 indexed citations
7.
Rody, Achim, et al.. (2022). Timing of antenatal steroid administration for imminent preterm birth: results of a prospective observational study in Germany. Archives of Gynecology and Obstetrics. 308(3). 839–847. 3 indexed citations
8.
Fortmann, Mats Ingmar, Alexander Humberg, Mariana Astiz, et al.. (2022). A Timely Administration of Antenatal Steroids Is Highly Protective Against Intraventricular Hemorrhage: An Observational Multicenter Cohort Study of Very Low Birth Weight Infants. Frontiers in Pediatrics. 10. 721355–721355. 14 indexed citations
10.
Boßung, Verena & Franziska Krähenmann. (2022). Stillen in der Praxis. PubMed Central. 27(6). 30–35.
11.
Boßung, Verena, et al.. (2021). Heterogenous use of misoprostol for induction of labour: results of an online survey among midwives in German-speaking countries. Archives of Gynecology and Obstetrics. 304(6). 1501–1511. 1 indexed citations
12.
Boßung, Verena, et al.. (2021). Smart Sensorik in der Schwangerschaft: Narratives Review über die Verlagerung der Schwangerschaftsvorsorge in den Smart Home Bereich. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 164. 35–43. 5 indexed citations
13.
Fortmann, Mats Ingmar, et al.. (2021). A Question of Timing: 10-year Retrospective Analysis on the Use of Antenatal Steroids for Imminent Preterm Birth. Zeitschrift für Geburtshilfe und Neonatologie. 225(6). 493–498. 1 indexed citations
14.
Astiz, Mariana, Isabel Heyde, Mats Ingmar Fortmann, et al.. (2020). The circadian phase of antenatal glucocorticoid treatment affects the risk of behavioral disorders. Nature Communications. 11(1). 3593–3593. 27 indexed citations
15.
Boßung, Verena, Mats Ingmar Fortmann, Christoph Fusch, et al.. (2020). Neonatal Outcome After Preeclampsia and HELLP Syndrome: A Population-Based Cohort Study in Germany. Frontiers in Pediatrics. 8. 579293–579293. 22 indexed citations
16.
Boßung, Verena & Achim Rody. (2018). Eine Frage des Timings: Retrospektive 10-Jahres-Analyse zur RDS-Prophylaxe bei Frühgeburten vor 34+0 SSW. Geburtshilfe und Frauenheilkunde. 1 indexed citations
17.
Humberg, Alexander, Christoph Härtel, Verena Boßung, et al.. (2017). Delivery mode and intraventricular hemorrhage risk in very-low-birth-weight infants: Observational data of the German Neonatal Network. European Journal of Obstetrics & Gynecology and Reproductive Biology. 212. 144–149. 57 indexed citations
18.
Hagmann, Henning, Verena Boßung, Abdel Ali Belaidi, et al.. (2014). Low-Molecular Weight Heparin Increases Circulating sFlt-1 Levels and Enhances Urinary Elimination. PLoS ONE. 9(1). e85258–e85258. 30 indexed citations
19.
Thadhani, Ravi, Tuelay Kisner, Henning Hagmann, et al.. (2011). Pilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia. Circulation. 124(8). 940–950. 236 indexed citations
20.
Boßung, Verena & Nadia Harbeck. (2009). Angiogenesis inhibitors in the management of breast cancer. Current Opinion in Obstetrics & Gynecology. 22(1). 79–86. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026